 |
PDF »
March 3, 2006
Cougar Biotechnology to Present at Cowen & Co. 26th Annual Health Care Conference
Los Angeles, CA, March 3, 2006 - Cougar Biotechnology, Inc, a privately held biotechnology company, today announced that Alan H. Auerbach, Chief Executive Officer and President of Cougar, will present at the Cowen & Co. 26th Annual Health Care Conference in Boston. Mr. Auerbach's presentation will occur on Tuesday, March 7, 2006 at 3:30 p.m. ET at the Boston Marriott Copley Place in Boston, Massachusetts.
About Cougar Biotechnology
Cougar Biotechnology, Inc. is a Los Angeles-based private biotechnology company established to in-license and develop clinical stage drugs, with a specific focus on the field of oncology. Cougar's oncology portfolio includes CB7630, which is currently being tested in a Phase I clinical trial in prostate cancer, CB3304, which is currently in a Phase I trial in non-Hodgkin's lymphoma and CB1089, which has been clinically tested in a number of solid tumor types.
Further information about Cougar Biotechnology can be found at www.cougarbiotechnology.com.
Contact
Alan H. Auerbach
Cougar Biotechnology, Inc.
+1 310 443 4209
ahauerbach@cougarbiotechnology.com
| | |
Cougar Biotechnology, Inc.
10990 Wilshire Blvd, Suite 1200
Los Angeles, CA 90024
(310) 943-8040 Main
(310) 943-8059 Fax |
